Armistice Capital »

Spdr Ser Tr s&p oilgas exp shares owned by Armistice Capital

Quarter-by-quarter ownership of Spdr Ser Tr s&p oilgas exp (XOP) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Spdr Ser Tr s&p oilgas exp

Tip: Access up to 7 years of quarterly data

All positions including Spdr Ser Tr s&p oilgas exp held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Spdr Ser Tr s&p oilgas exp by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $497k 2.7k 181.83

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Agios Pharmaceuticals (AGIO)
Cytokinetics Com New (CYTK)
Ptc Therapeutics I (PTCT)
Travere Therapeutics (TVTX)
Madrigal Pharmaceuticals (MDGL)
Immunovant (IMVT)
Supernus Pharmaceuticals (SUPN)
Neurocrine Biosciences (NBIX)
Freshpet (FRPT)
Incyte Corporation (INCY)
Dyne Therapeutics (DYN)
Amazon (AMZN)
Ironwood Pharmaceuticals Com Cl A (IRWD)

View all positions for Armistice Capital

Top funds holding Spdr Ser Tr s&p oilgas exp

Susquehanna International
Goldman Sachs Group
Jane Street
Citadel Advisors
Nomura Holdings
Healthcare Of Ontario Pension Plan Trust Fund
Citigroup
Millennium Management
Morgan Stanley
Bank of America Corporation
Tudor Investment Corporation
UBS Group
Encompass Capital Advisors
Soros Fund Management
Invesco

View all funds holding Spdr Ser Tr s&p oilgas exp